Literature DB >> 22711472

First case of a Japanese girl with Myhre syndrome due to a heterozygous SMAD4 mutation.

Yumi Asakura1, Koji Muroya, Takeshi Sato, Kenji Kurosawa, Gen Nishimura, Masanori Adachi.   

Abstract

This article reports the first case of a Japanese girl with molecularly confirmed Myhre syndrome (MS). The patient was 9 years old at her first visit, and she had been diagnosed with unknown skeletal dysplasia. Her phenotype fulfilled the clinical and radiological criteria for MS, such as typical facies with prognathism, hearing impairment, short stature, square body shape, and limited joint mobility. The thick calvarium and thick skin were clues to the clinical diagnosis of MS. A heterozygous mutation in the mothers-against-DPP homolog 4 (SMAD4) gene has been reported to cause MS. We sequenced SMAD4 using standard PCR-based technique and identified a recurrent mutation (p.Ile500 Thr). She attained menarche before 11 years of age; however, she developed oligomenorrhea after a few years of 40-day cycles, necessitating hormone replacement therapy. The luteinizing hormone-releasing hormone (LHRH) tests suggested abnormalities related to hypothalamo-hypophyseal malfunction. Previous reports on MS described early menarche in girls and early or delayed puberty and cryptorchidism in boys. Therefore, we recommend performing an endocrinological evaluation of the hypothalamo-hypophyseal-gonadal axis in patients with MS to clarify whether hormonal abnormalities are associated with the syndrome.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22711472     DOI: 10.1002/ajmg.a.35440

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  4 in total

1.  Natural history and life-threatening complications in Myhre syndrome and review of the literature.

Authors:  Livia Garavelli; Ilenia Maini; Federica Baccilieri; Ivan Ivanovski; Marzia Pollazzon; Simonetta Rosato; Lorenzo Iughetti; Sheila Unger; Andrea Superti-Furga; Marco Tartaglia
Journal:  Eur J Pediatr       Date:  2016-08-25       Impact factor: 3.183

2.  SMAD4 mutations causing Myhre syndrome result in disorganization of extracellular matrix improved by losartan.

Authors:  Pasquale Piccolo; Pratibha Mithbaokar; Valeria Sabatino; John Tolmie; Daniela Melis; Maria Cristina Schiaffino; Mirella Filocamo; Generoso Andria; Nicola Brunetti-Pierri
Journal:  Eur J Hum Genet       Date:  2014-01-08       Impact factor: 4.246

3.  First documented case of Myhre syndrome in Romania: A case report.

Authors:  Andreea Cătană; Ruxandra Simonescu-Colan; Zina Cuzmici-Barabaș; Diana Militaru; Irina Iordănescu; Mariela Sanda Militaru
Journal:  Exp Ther Med       Date:  2022-03-10       Impact factor: 2.447

4.  Natural history of Myhre syndrome.

Authors:  David Dawei Yang; Marlene Rio; Caroline Michot; Nathalie Boddaert; Wael Yacoub; Nicolas Garcelon; Briac Thierry; Damien Bonnet; Sophie Rondeau; Dominique Herve; Stephanie Guey; Francois Angoulvant; Valerie Cormier-Daire
Journal:  Orphanet J Rare Dis       Date:  2022-07-30       Impact factor: 4.303

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.